Hwang Kuk Hyoun 4
4 · Bellevue Life Sciences Acquisition Corp. · Filed Mar 27, 2023
Insider Transaction Report
Form 4
Hwang Kuk Hyoun
DirectorPresident and CEO10% Owner
Transactions
- Other
Common Stock
2023-03-23−20,000→ 2,000,500 total(indirect: By LLC) - Other
Warrant for Common Stock
2023-03-23−20,000→ 370,000 total(indirect: By LLC)Exercise: $11.50→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]Represents shares of common stock held by Bellevue Global Life Sciences Investors LLC the sponsor of the Issuer (the "Sponsor"), whose general partner is Bellevue Capital Management LLC ("Bellevue Capital"). Kuk Hyoun Hwang is the managing partner of Bellevue Capital and has voting and dispositive power over the shares held by the Sponsor.
- [F2]Represents the shares transferred by the Sponsor to Mr. David Jin Yoo for service as Chief Financial Officer.
- [F3]Represents the warrant to purchase a total of 20,000 shares of the Issuer, transferred from the Sponsor to Mr. David Jin Yoo for his service as Chief Financial Officer. Each warrant will become exercisable 30 days after the Issuer's initial business combination. Each warrant will expire five years after the completion of the Issuer's initial business combination, or earlier upon redemption or liquidation. Each warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustments.